P04.17
Newborn affected by maternal use of sedative-hypnotics
Clinical Classification Guidelines
Medical Intelligence & Overview
ICD-10 code P04.17 refers to newborns who are affected by maternal use of sedative-hypnotic medications during pregnancy. These medications, often prescribed for sleep or anxiety issues, can pass through the placenta and influence the developing fetal nervous system. While these drugs may help the mother manage health conditions, their use during pregnancy can pose risks for the newborn, necessitating careful monitoring and management.
Causes & Symptoms
Clinical Causes: Maternal use of prescription sedative-hypnotic drugs such as benzodiazepines, barbiturates, or other sleep aids during pregnancy. Unintentional or unplanned pregnancy leading to continued sedative intake without medical guidance. Inadequate prenatal care that does not identify or address medication use during pregnancy. Substance dependence and the need for detoxification during pregnancy.
Key Symptoms: Altered alertness levels, including excessive sleepiness or lethargy. Poor feeding and difficulty coordinating sucking and swallowing. Respiratory depression or irregular breathing patterns. Muscle hypotonia or decreased muscle tone. Jitteriness or signs of irritability, which may be indicative of withdrawal or neurological effects. Low birth weight and small gestational age in some cases. Possible seizures or neurological symptoms in severe cases.
Diagnostic & Treatment
Diagnosis Path: The diagnosis of conditions related to maternal sedative-hypnotic use is typically based on a thorough review of maternal medication history, physical examinations of the newborn, and observation of clinical symptoms. Additional testing, such as blood tests or imaging, may be used to assess the extent of drug effects or related complications. Healthcare providers may also utilize neonatal withdrawal scoring systems to determine the severity of symptoms and guide management.
Treatment Protocols: Management of newborns affected by maternal use of sedative-hypnotics involves supportive care to stabilize vital signs and address specific symptoms. Common interventions include:
Clinical Advice & FAQs
Billing Guidance
Is P04.17 a billable ICD-10 code?
Yes, P04.17 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report P04.17?
Clinical documentation must specify the nature of Newborn affected by maternal use of sedative-hypnotics and any associated comorbidities for accurate reporting.
Cite this Clinical Reference